91 related articles for article (PubMed ID: 17568627)
21. [Inflammatory bowel diseases: an immunological approach].
Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
[TBL] [Abstract][Full Text] [Related]
22. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets.
Roy N; Barnett M; Knoch B; Dommels Y; McNabb W
Mutat Res; 2007 Sep; 622(1-2):103-16. PubMed ID: 17574631
[TBL] [Abstract][Full Text] [Related]
23. Decoding the pyramid: a systems-biological approach to nutrigenomics.
Kaput J
Ann N Y Acad Sci; 2005 Dec; 1055():64-79. PubMed ID: 16387719
[TBL] [Abstract][Full Text] [Related]
24. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
[TBL] [Abstract][Full Text] [Related]
25. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.
Haller D
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S6-9. PubMed ID: 20535026
[TBL] [Abstract][Full Text] [Related]
26. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
[TBL] [Abstract][Full Text] [Related]
27. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
28. NOD2 receptors in adenopituitary folliculostellate cells: expression and function.
Correa-de-Santana E; Fröhlich B; Labeur M; Páez-Pereda M; Theodoropoulou M; Monteserin JL; Renner U; Stalla GK
J Endocrinol; 2009 Oct; 203(1):111-22. PubMed ID: 19608614
[TBL] [Abstract][Full Text] [Related]
29. NF-kappaB in inflammatory bowel disease.
Atreya I; Atreya R; Neurath MF
J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
[TBL] [Abstract][Full Text] [Related]
30. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
32. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease.
Guerreiro CS; Ferreira P; Tavares L; Santos PM; Neves M; Brito M; Cravo M
Am J Gastroenterol; 2009 Sep; 104(9):2241-9. PubMed ID: 19550417
[TBL] [Abstract][Full Text] [Related]
33. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE
Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach.
Targan SR; Karp LC
Curr Opin Gastroenterol; 2007 Jul; 23(4):390-4. PubMed ID: 17545774
[TBL] [Abstract][Full Text] [Related]
35. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease.
Barnett M; Bermingham E; McNabb W; Bassett S; Armstrong K; Rounce J; Roy N
Mutat Res; 2010 Aug; 690(1-2):71-80. PubMed ID: 20188748
[TBL] [Abstract][Full Text] [Related]
36. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
[TBL] [Abstract][Full Text] [Related]
37. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
38. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
[TBL] [Abstract][Full Text] [Related]
39. Nutrition and cancer prevention: diet-gene interactions.
Mathers JC
Proc Nutr Soc; 2003 Aug; 62(3):605-10. PubMed ID: 14692596
[TBL] [Abstract][Full Text] [Related]
40. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.
Ghorpade DS; Sinha AY; Holla S; Singh V; Balaji KN
J Biol Chem; 2013 Nov; 288(46):33037-48. PubMed ID: 24092752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
